J. Svensson

发表

The Gothenburg MCI study: Design and distribution of Alzheimer’s disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

K. Blennow, A. Wallin, A. Nordlund, 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.

L. Lönn, L. Sjöström, J. Svensson, 1998, The Journal of clinical endocrinology and metabolism.

Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy

J. Svensson, L. Rylander, M. Thorén, 2013, Psychoneuroendocrinology.

Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.

J. Svensson, M. Kołtowska-Häggström, H. Koppeschaar, 2006, European journal of endocrinology.

Long-Term Efficacy and Safety of Somatropin for Adult Growth Hormone Deficiency

J. Svensson, G. Johannson, 2003, Treatments in endocrinology.

Fifteen years of GH replacement improves body composition and cardiovascular risk factors

J. Svensson, B. Bengtsson, G. Johannsson, 2013, European journal of endocrinology.

Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency

J. Svensson, B. Bengtsson, G. Johannsson, 2011, European journal of endocrinology.

P23 Effects of 3-year growth hormone (GH) replacement therapy on bone mineral density in younger and elderly adults with adult onset GH deficiency

J. Svensson, B. Bengtsson, G. Johannsson, 2010 .

Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.

J. Svensson, P. Harris, M. Kołtowska-Häggström, 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults.

J. Svensson, I. Bosaeus, G. Johannsson, 2007, The Journal of clinical endocrinology and metabolism.

Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.

J. Svensson, B. Bengtsson, G. Johannsson, 2006, The Journal of clinical endocrinology and metabolism.

GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood.

A. Iranmanesh, J. Svensson, B. Bengtsson, 2006, European journal of endocrinology.

Effects of GH and insulin-like growth factor-I on body composition

L. Lönn, J. Svensson, B. Bengtsson, 2003, Journal of endocrinological investigation.

A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices.

M. Alpsten, J. Svensson, I. Bosaeus, 2001, The Journal of clinical endocrinology and metabolism.

A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men.

M. Taskinen, J. Svensson, O. Wiklund, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Growth hormone secretagogues

Johan Svensson, J. Svensson, 2000 .

Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).

M. Taskinen, J. Svensson, J. Jansson, 1999, The Journal of clinical endocrinology and metabolism.

Clinical and Experimental Effects of Growth Hormone Secretagogues on Various Organ Systems

J. Svensson, B. Bengtsson, 1999, Hormone Research in Paediatrics.

Growth hormone secretagogues as therapeutic agents.

J. Svensson, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Insulin‐like growth factor‐I in growth hormone‐deficient adults: relationship to population‐based normal values, body composition and insulin tolerance test

J. Svensson, B. Bengtsson, G. Johannsson, 1997, Clinical endocrinology.

Stimulation of both estrogen and androgen receptors maintains skeletal muscle mass in gonadectomized male mice but mainly via different pathways.

Johan Svensson, K. Sjögren, S. Movérare-Skrtic, 2010, Journal of molecular endocrinology.

Factors influencing insulin sensitivity in patients with mild primary hyperparathyroidism before and after parathyroidectomy

D. Mellström, J. Svensson, L. Bondeson, 2012, Scandinavian journal of clinical and laboratory investigation.

Increased plasma concentrations of N‐terminal pro‐B‐type natriuretic peptide in patients with mild primary hyperparathyroidism

J. Svensson, L. Bondeson, A. Bondeson, 2006, Clinical endocrinology.

Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk

A. Fagan, J. Morris, K. Blennow, 2022, PloS one.

Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer’s Disease

A. Wallin, J. Svensson, C. Eckerström, 2022, Journal of Alzheimer's disease : JAD.

Identifying the Value of an eHealth Intervention Aimed at Cognitive Impairments: Observational Study in Different Contexts and Service Models

J. Svensson, H. Eriksson, S. Lifvergren, 2020, Journal of medical Internet research.

Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis

Bjoern Peters, J. Svensson, H. Hadimeri, 2022, PloS one.

Safety aspects of GH replacement.

J. Svensson, B. Bengtsson, 2009, European journal of endocrinology.

Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.

J. Svensson, B. Bengtsson, J. Johansson, 2002, The Journal of clinical endocrinology and metabolism.

Leukocyte telomere length is not associated with mortality in older men

D. Mellström, S. Movérare-Skrtic, J. Svensson, 2014, Experimental Gerontology.

Reduced Bone Mass and Muscle Strength in Male 5α-Reductase Type 1 Inactivated Mice

K. Sjögren, M. Lagerquist, S. Movérare-Skrtic, 2011, PloS one.

Growth hormone replacement therapy and insulin sensitivity.

J. Svensson, B. Bengtsson, 2003, The Journal of clinical endocrinology and metabolism.

Growth hormone and ageing.

J. Svensson, B. Bengtsson, G. Johannsson, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Adiponectin, leptin, and erythrocyte sodium/lithium countertransport activity, but not resistin, are related to glucose metabolism in growth hormone-deficient adults.

J. Svensson, P. Lundberg, G. Johannsson, 2005, The Journal of clinical endocrinology and metabolism.

Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women

K. Blennow, O. Hansson, C. Ohlsson, 2011, Clinical endocrinology.

Liver-derived IGF-I is not required for protection against osteoarthritis in male mice.

C. Ohlsson, J. Svensson, S. Ralston, 2019, American journal of physiology. Endocrinology and metabolism.

Deficiency of liver-derived insulin-like growth factor-I (IGF-I) does not interfere with the skin wound healing rate

C. Ohlsson, J. Svensson, J. Jansson, 2018, PloS one.

Liver-derived IGF 1 enhances the a ndrogenic response in prostate

K. Sjögren, M. Lagerquist, S. Movérare-Skrtic, 2008 .

Liver-derived IGF1 enhances the androgenic response in prostate.

K. Sjögren, M. Lagerquist, S. Movérare-Skrtic, 2008, The Journal of endocrinology.

Liver-Derived IGF-I Regulates Mean Life Span in Mice

K. Sjögren, N. Andersson, C. Ohlsson, 2011, PloS one.

Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency

M. M. Ilondo, J. Svensson, M. Korbonits, 2003, Clinical endocrinology.

Increased orderliness of growth hormone (GH) secretion in GH-deficient adults with low serum insulin-like growth factor I.

A. Iranmanesh, J. Svensson, B. Bengtsson, 2002, The Journal of clinical endocrinology and metabolism.

Increased diet-induced fatty streak formation in female mice with deficiency of liver-derived insulin-like growth factor-I

J. Borén, K. Sjögren, C. Ohlsson, 2015, Endocrine.

Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.

J. Svensson, I. Bosaeus, G. Johannsson, 2007, European journal of endocrinology.

The effects of five‐year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients

J. Svensson, K. Sunnerhagen, B. Bengtsson, 2005, Clinical endocrinology.

Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men

D. Mellström, C. Ohlsson, J. Svensson, 2021, Osteoporosis International.

Treatment with the Oral Growth Hormone Secretagogue MK‐677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males

S. Mohan, C. Ohlsson, J. Svensson, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Association Between Levels of Serum Insulin-like Growth Factor I and Functional Recovery, Mortality, and Recurrent Stroke at a 7-year Follow-up.

C. Blomstrand, J. Svensson, M. Åberg, 2020, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Effects of 18 months of GH replacement on cardiovascular risk factors and quality of life in GH deficient adults; a randomized controlled trial using a fixed very low and a standard dose of GH.

J. Svensson, G. Johannsson, G. Götherström, 2022, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.

J. Svensson, K. Albertsson-Wikland, J. Dahlgren, 2009, The Journal of clinical endocrinology and metabolism.

Liver-derived IGF-I regulates exploratory activity in old mice.

K. Sjögren, C. Ohlsson, J. Svensson, 2005, American journal of physiology. Endocrinology and metabolism.

Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP‐6

J. Svensson, J. Jansson, L. Frohman, 1998, Clinical endocrinology.

Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).

M. Taskinen, J. Svensson, J. Jansson, 1999, The Journal of clinical endocrinology and metabolism.

Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial.

L. Lönn, J. Svensson, B. Bengtsson, 2007, The Journal of clinical endocrinology and metabolism.

Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism

J. Svensson, L. Bondeson, A. Bondeson, 2011, Scandinavian journal of clinical and laboratory investigation.

Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma.

J. Svensson, G. Wallin, M. Abraham-Nordling, 2008, European journal of endocrinology.

Liver-derived IGF-I regulates cortical bone mass but is dispensable for the osteogenic response to mechanical loading in female mice.

K. Sjögren, S. Windahl, C. Ohlsson, 2016, American journal of physiology. Endocrinology and metabolism.

Liver-derived endocrine IGF-I is not critical for activation of skeletal muscle protein synthesis following oral feeding

C. Ohlsson, J. Svensson, K. Lundholm, 2013, BMC Physiology.

Body Composition and Quality of Life as Markers of the Efficacy of Growth Hormone Replacement Therapy in Adults

J. Svensson, B. Bengtsson, G. Johannsson, 2001, Hormone Research in Paediatrics.

Effects of growth hormone and its secretagogues on bone

C. Ohlsson, J. Svensson, J. Jansson, 2001, Endocrine.

The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms.

J. Svensson, B. Bengtsson, L. Carlsson, 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats.

C. Ohlsson, J. Svensson, J. Jansson, 2000, The Journal of endocrinology.

The association between the IGF-I axis, thyroid hormones and cortical bone in patients with mild primary hyperparathyroidism

J. Svensson, L. Bondeson, A. Bondeson, 2013, Scandinavian journal of clinical and laboratory investigation.

Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study.

J. Svensson, L. Bondeson, A. Bondeson, 2004, Surgery.

Fracture Incidence in GH‐Deficient Patients on Complete Hormone Replacement Including GH

J. Svensson, L. Hagmar, L. Rylander, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Growth hormone (GH) replacement in women in relation to their endogenous GH secretion.

J. Svensson, J. Jansson, 2004, The Journal of clinical endocrinology and metabolism.

Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone–insulin‐like growth factor I axis in growth hormone–deficient children

J. Svensson, E. Codner, F. Cassorla, 2001, Clinical pharmacology and therapeutics.

Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation.

J. Svensson, B. Bengtsson, G. Johannsson, 2013, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.

J. Svensson, K. Sunnerhagen, B. Bengtsson, 2001, The Journal of clinical endocrinology and metabolism.

Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency.

J. Svensson, B. Bengtsson, G. Johannsson, 2017, European journal of endocrinology.

Different modes of GH administration influence gene expression in the male rat brain.

J. Svensson, M. Åberg, N. Åberg, 2014, The Journal of endocrinology.

Mode of GH administration and gene expression in the female rat brain.

J. Svensson, M. Åberg, N. Åberg, 2017, The Journal of endocrinology.

The association between long-term glycemic control and all-cause mortality is different among older versus younger patients with diabetes mellitus and maintenance hemodialysis treatment.

J. Svensson, S. Nasic, H. Rydell, 2022, Diabetes research and clinical practice.

Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease

K. Blennow, O. Hansson, H. Zetterberg, 2013, Psychoneuroendocrinology.

Total opioid‐free general anaesthesia can improve postoperative outcomes after surgery, without evidence of adverse effects on patient safety and pain management: A systematic review and meta‐analysis

J. Svensson, P. Andréll, S. Thörn, 2021, Acta anaesthesiologica Scandinavica.

The role of liver-derived insulin-like growth factor-I.

K. Sjögren, S. Mohan, C. Ohlsson, 2009, Endocrine reviews.

Management of growth hormone deficiency in adults.

J. Svensson, G. Johannsson, A. Nilsson, 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency

J. Svensson, B. Bengtsson, G. Johannsson, 2011, European journal of endocrinology.

Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke

K. Blennow, C. Blomstrand, H. Zetterberg, 2016, Stroke.

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease

K. Blennow, H. Zetterberg, J. Svensson, 2021, Alzheimer's & dementia.

The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk

K. Blennow, J. Molinuevo, M. Ewers, 2019, Science Translational Medicine.

Genomewide meta‐analysis identifies loci associated with IGF‐I and IGFBP‐3 levels with impact on age‐related traits

Sara M. Willems, Jonathan H. Chung, Toshiko Tanaka, 2016, Aging cell.

Both low and high serum IGF-I levels associate with cancer mortality in older men.

M. Petzold, D. Mellström, C. Ohlsson, 2012, Journal of Clinical Endocrinology and Metabolism.

Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementia

A. Nordlund, J. Svensson, A. Wallin, 2017, Psychoneuroendocrinology.

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

K. Blennow, O. Hansson, H. Zetterberg, 2013, Psychoneuroendocrinology.

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases

K. Blennow, O. Hansson, H. Zetterberg, 2010, Front. Ag. Neurosci..

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease

Johan Svensson, Anders Wallin, Henrik Zetterberg, 2016, Dementia and Geriatric Cognitive Disorders Extra.

Insulin-Like Growth Factor-II and Ischemic Stroke—A Prospective Observational Study

C. Blomstrand, J. Svensson, N. Åberg, 2021, Life.

Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly men.

M. Petzold, D. Mellström, C. Ohlsson, 2014, The Journal of clinical endocrinology and metabolism.

The novel antidepressant ketamine enhances dentate gyrus proliferation with no effects on synaptic plasticity or hippocampal function in depressive‐like rats

E. Hanse, J. Svensson, H. Kuhn, 2018, Acta physiologica.

Leukocyte Telomere Length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's Disease: A pilot study

K. Blennow, O. Hansson, S. Movérare-Skrtic, 2012, Experimental Gerontology.

Synthetic standard aided quantification and structural characterization of amyloid-beta glycopeptides enriched from cerebrospinal fluid of Alzheimer’s disease patients

K. Blennow, J. Svensson, A. Wallin, 2019, Scientific Reports.

Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer’s Disease and Other Neurodegenerative Disorders

K. Blennow, H. Hampel, S. Lista, 2017, NeuroMolecular Medicine.

Circulating levels of vascular endothelial growth factor and post‐stroke long‐term functional outcome

K. Blennow, H. Zetterberg, J. Svensson, 2020, Acta neurologica Scandinavica.

Growth Hormone and Neuronal Hemoglobin in the Brain—Roles in Neuroprotection and Neurodegenerative Diseases

J. Svensson, H. Kuhn, M. Åberg, 2021, Frontiers in Endocrinology.

Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease

J. Svensson, K. Sunnerhagen, G. Johannsson, 2004, Clinical endocrinology.

Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease2

Johan Svensson, Elisabeth Kapaki, A. Wallin, 2018, Journal of Alzheimer's disease : JAD.

Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults.

J. Svensson, B. Bengtsson, G. Johannsson, 2009, The Journal of clinical endocrinology and metabolism.

The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women.

L. Lönn, J. Svensson, G. Johannsson, 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease

K. Blennow, J. Schott, R. Paterson, 2016, Molecular Neurodegeneration.

Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.

J. Svensson, T. Rosén, G. Johannsson, 2004, The Journal of clinical endocrinology and metabolism.

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology

Nick C Fox, J. Schott, R. Paterson, 2016, Translational psychiatry.

THE MS4A GENE CLUSTER IS A KEY MODULATOR OF SOLUBLE TREM2 AND ALZHEIMER DISEASE RISK

K. Blennow, J. Molinuevo, M. Ewers, 2018, Alzheimer's & Dementia.

Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease

K. Blennow, O. Hansson, H. Zetterberg, 2013, PloS one.

Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength.

J. Svensson, K. Sunnerhagen, G. Johannsson, 2003, The Journal of clinical endocrinology and metabolism.

Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders

M. Eckerström, J. Svensson, C. Eckerström, 2021, Alzheimer's & dementia.

Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia

A. Wallin, M. Jonsson, M. Göthlin, 2019, Journal of Alzheimer's disease : JAD.

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample

A. Wallin, E. Hessen, A. Nordlund, 2017, Alzheimer's & dementia.

The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms.

D. Walsh, H. Zetterberg, J. Svensson, 2013, Journal of Alzheimer's disease : JAD.

Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.

K. Blennow, H. Zetterberg, J. Svensson, 2020, Journal of Alzheimer's disease : JAD.

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment

K. Blennow, H. Zetterberg, J. Svensson, 2017, PloS one.

Serum insulin-like growth factor-I concentration is associated with leukocyte telomere length in a population-based cohort of elderly men.

D. Mellström, S. Movérare-Skrtic, C. Ohlsson, 2009, The Journal of clinical endocrinology and metabolism.

Patients with the Subcortical Small Vessel Type of Dementia Have Disturbed Cardiometabolic Risk Profile.

A. Wallin, J. Svensson, Elin Axelsson, 2020, Journal of Alzheimer's disease : JAD.

Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.

A. Wallin, M. Jonsson, M. Göthlin, 2019, Journal of Alzheimer's disease : JAD.

Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

K. Blennow, A. Wallin, A. Nordlund, 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Higher thyroid function is associated with accelerated hippocampal volume loss in Alzheimer’s disease

A. Wallin, J. Svensson, C. Eckerström, 2022, Psychoneuroendocrinology.

Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice.

T. Hökfelt, T. Archer, C. Ohlsson, 2006, The Journal of endocrinology.

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

J. Svensson, B. Bengtsson, T. Rosén, 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone.

B. Norrving, J. Svensson, L. Hagmar, 2007, The Journal of clinical endocrinology and metabolism.

Low serum concentration of free triiodothyronine (FT3) is associated with increased risk of Alzheimer’s disease

J. Svensson, A. Wallin, Alexandra Horvath, 2019, Psychoneuroendocrinology.

Dihydrotestosterone Treatment Results in Obesity and Altered Lipid Metabolism in Orchidectomized Mice

J. Gustafsson, S. Movérare-Skrtic, N. Andersson, 2006, Obesity.

Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women

J. Svensson, L. Bondeson, A. Bondeson, 2006, Clinical endocrinology.

Patients with Alzheimer's Disease Have Increased Levels of Insulin-like Growth Factor-I in Serum but not in Cerebrospinal Fluid.

A. Wallin, J. Svensson, Alexandra Horvath, 2020, Journal of Alzheimer's disease : JAD.

Chapter 15 – GHRP-s in Human Obesity

J. Svensson, J. Jansson, B. Bengtsson, 1999 .

Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility

K. Blennow, O. Hansson, H. Zetterberg, 2011, NeuroMolecular Medicine.

Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.

J. Svensson, K. Sunnerhagen, G. Johannsson, 2008, The Journal of clinical endocrinology and metabolism.

Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk

A. Fagan, J. Morris, K. Blennow, 2021, medRxiv.

Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss.

N. Andersson, C. Ohlsson, J. Svensson, 2006, Bone.

Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.

K. Blennow, H. Zetterberg, J. Svensson, 2015, Journal of Alzheimer's disease : JAD.

Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement.

Johan Svensson, J. Svensson, B. Bengtsson, 2010, European journal of endocrinology.

Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression.

G. Bergström, K. Sjögren, S. Mohan, 2007, The Journal of endocrinology.

The amyloid-β degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease

K. Blennow, L. Lannfelt, M. Ingelsson, 2014, Neuroscience Letters.

Insulin‐like growth factor I and risk of incident cancer in elderly men – results from MrOS (Osteoporotic Fractures in Men) in Sweden

Johan Svensson, Claes Ohlsson, Max Petzold, 2016, Clinical endocrinology.

Homeostasis model assessment of insulin resistance and outcome of ischemic stroke in non-diabetic patients - a prospective observational study

C. Blomstrand, J. Svensson, N. Åberg, 2019, BMC neurology.

The Role of IGF-1 for Fracture Risk in Men

K. Sjögren, C. Ohlsson, J. Svensson, 2012, Front. Endocrin..

Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity.

L. Lönn, A. Iranmanesh, J. Svensson, 2006, European journal of endocrinology.

Testosterone associates differently with body mass index and age in serum and cerebrospinal fluid in men

A. Wallin, C. Ohlsson, J. Svensson, 2022, Journal of internal medicine.

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.

K. Blennow, O. Hansson, H. Zetterberg, 2011, Journal of Alzheimer's disease : JAD.

Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease.

H. Zetterberg, J. Svensson, I. Horváth, 2016, ACS chemical neuroscience.

Importance of circulating IGF-1 for normal cardiac morphology, function and post infarction remodeling.

C. Ohlsson, J. Svensson, E. Omerovic, 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Both Estrogen and Androgen Receptor Stimulation Maintains Skeletal Muscle Mass 1 in Gonadectomized Male Mice but mainly via Different Pathways 2

K. Sjögren, S. Movérare-Skrtic, S. Windahl, 2010 .

Higher CSF/serum free‐T4 ratio is associated with improvement of quality of life during treatment with L‐thyroxine

K. Blennow, B. Wandt, H. Zetterberg, 2023, Journal of neuroendocrinology.

Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism – A pilot study

K. Blennow, B. Wandt, J. Svensson, 2020, Journal of clinical & translational endocrinology.

Converging pathways of chromogranin and amyloid metabolism in the brain.

K. Blennow, O. Hansson, H. Zetterberg, 2010, Journal of Alzheimer's disease : JAD.

Genetic variation at the IGF1 locus shows association with post-stroke outcome and to circulating IGF1.

C. Blomstrand, J. Svensson, N. Åberg, 2013, European journal of endocrinology.

Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.

M. Jonsson, J. Svensson, M. Bjerke, 2021, Journal of Alzheimer's disease : JAD.

Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease

K. Blennow, H. Zetterberg, J. Svensson, 2015, Neuroscience Letters.

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.

K. Blennow, H. Zetterberg, J. Svensson, 2017, Journal of Alzheimer's disease : JAD.

Growth hormone and the cardiovascular function.

J. Svensson, J. Isgaard, Å. Tivesten, 2005, Minerva Endocrinologica.

The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men.

P. Björntorp, B. McEwen, J. Svensson, 2000, Obesity research.

Sleep apnoea and quality of life in growth hormone (GH)‐deficient adults before and after 6 months of GH replacement therapy

J. Svensson, J. Hedner, L. Grote, 2006, Clinical endocrinology.

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease

K. Blennow, J. Schott, R. Paterson, 2016, Molecular Neurodegeneration.

Influence of Cardiovascular Fitness and Muscle Strength in Early Adulthood on Long-Term Risk of Stroke in Swedish Men

K. Torén, J. Svensson, H. Kuhn, 2015, Stroke.

Genetic variation at the IGF 1 locus shows association with post-stroke outcome and to circulating IGF 1

C. Blomstrand, J. Svensson, N. Åberg, 2013 .

Circulating granulocyte colony-stimulating factor and functional outcome after ischemic stroke: an observational study

K. Blennow, C. Blomstrand, H. Zetterberg, 2021, Neurological research.

Altered levels of circulating insulin-like growth factor I (IGF-I) following ischemic stroke are associated with outcome - a prospective observational study

C. Blomstrand, J. Svensson, H. Kuhn, 2018, BMC Neurology.

Serum IGFBP-1 Concentration as a Predictor of Outcome after Ischemic Stroke—A Prospective Observational Study

K. Blennow, H. Zetterberg, J. Svensson, 2023, International journal of molecular sciences.

Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity.

L. Lönn, J. Svensson, J. Hedner, 2010, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality.

P. Dahlqvist, J. Svensson, G. Johannsson, 2013, The Journal of clinical endocrinology and metabolism.

Cognitive medicine – a new approach in health care science

L. Nyberg, L. Wahlund, A. Wallin, 2018, BMC Psychiatry.

Altered thyroid hormone profile in patients with Alzheimer’s disease

A. Wallin, J. Svensson, C. Eckerström, 2020, Psychoneuroendocrinology.

Serum erythropoietin and outcome after ischaemic stroke: a prospective study

K. Blennow, C. Blomstrand, H. Zetterberg, 2016, BMJ Open.

Blood‐brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein‐β in patients with subcortical small‐vessel disease

K. Blennow, M. Jonsson, H. Zetterberg, 2022, Alzheimer's & dementia.

Cerebrospinal fluid stanniocalcin-1: no relation to Alzheimer’s disease but potentially to other dementia disorders

K. Blennow, H. Hampel, S. Lista, 2017 .